Terumo Establishes Corporate Venture Capital "Terumo Ventures"
Terumo has established Terumo Ventures, a Corporate Venture Capital (CVC) organization within Terumo Americas Holding, aimed at leading the Group's venture investments. Terumo Ventures will invest US$ 75 million over the next five years in early-stage companies in fields like cardiovascular disease, chronic disease treatment, and digital technologies. The CVC operates in global innovation hubs, such as Massachusetts and California.
Since 2013, Terumo has been building relationships with medtech start-ups through investments in venture capital funds in the US and China. The new CVC aims to increase agility in identifying and executing venture investments, accelerating the acquisition of cutting-edge technologies, and developing a robust M&A pipeline.
Aligned with its 5-Year Growth Strategy 'GS26' and long-term vision 'From Devices to Solutions,' Terumo aims to enhance innovation capabilities. This includes a new director position managing innovation-related functions and fostering cross-functional collaboration.
Terumo ha istituito Terumo Ventures, un'organizzazione di Corporate Venture Capital (CVC) all'interno di Terumo Americas Holding, con l'obiettivo di guidare gli investimenti in venture del Gruppo. Terumo Ventures investirà 75 milioni di US$ nei prossimi cinque anni in aziende in fase iniziale nei settori come le malattie cardiovascolari, il trattamento delle malattie croniche e le tecnologie digitali. Il CVC opera in hub di innovazione globali, come il Massachusetts e la California.
Dal 2013, Terumo ha costruito relazioni con start-up medtech attraverso investimenti in fondi di venture capital negli Stati Uniti e in Cina. Il nuovo CVC mira ad aumentare l'agilità nell'identificare ed eseguire investimenti in venture, accelerando l'acquisizione di tecnologie all'avanguardia e sviluppando un robusto pipeline di M&A.
Allineata alla sua Strategia di Crescita quinquennale 'GS26' e alla visione a lungo termine 'Da Dispositivi a Soluzioni', Terumo punta a migliorare le capacità di innovazione. Questo include una nuova posizione di direttore che gestirà le funzioni legate all'innovazione e promuoverà la collaborazione interfunzionale.
Terumo ha establecido Terumo Ventures, una organización de Corporate Venture Capital (CVC) dentro de Terumo Americas Holding, con el objetivo de liderar las inversiones en venture del Grupo. Terumo Ventures invertirá 75 millones de US$ en los próximos cinco años en empresas en etapa inicial en campos como enfermedades cardiovasculares, tratamiento de enfermedades crónicas y tecnologías digitales. El CVC opera en centros de innovación globales, como Massachusetts y California.
Desde 2013, Terumo ha estado construyendo relaciones con startups de medtech a través de inversiones en fondos de capital de riesgo en EE. UU. y China. El nuevo CVC tiene como objetivo aumentar la agilidad en la identificación y ejecución de inversiones en venture, acelerando la adquisición de tecnologías de vanguardia y desarrollando una sólida cartera de M&A.
En línea con su Estrategia de Crecimiento de 5 años 'GS26' y su visión a largo plazo 'De Dispositivos a Soluciones', Terumo busca mejorar las capacidades de innovación. Esto incluye un nuevo puesto de director para gestionar funciones relacionadas con la innovación y fomentar la colaboración entre funciones.
테룸오는 테룸오 벤처스를 설립했습니다. 이는 테룸오 아메리카스 홀딩 내의 기업 벤처 캐피탈(CVC) 조직으로, 그룹의 벤처 투자 방향을 이끌기 위한 것입니다. 테룸오 벤처스는 향후 5년 동안 심장 혈관 질환, 만성 질환 치료 및 디지털 기술과 같은 분야의 초기 단계 기업에 7500만 달러를 투자할 예정입니다. 이 CVC는 매사추세츠와 캘리포니아와 같은 글로벌 혁신 중심지에서 운영됩니다.
2013년 이후로 테룸오는 미국과 중국의 벤처 캐피탈 펀드에 대한 투자를 통해 메드테크 스타트업과의 관계를 구축해왔습니다. 새로운 CVC는 벤처 투자 식별 및 실행의 민첩성을 높이고, 최첨단 기술의 획득을 가속화하며, 탄탄한 M&A 파이프라인을 개발하는 것을 목표로 하고 있습니다.
'GS26' 이라는 5년 성장 전략 및 '장치에서 솔루션으로'라는 장기 비전과 일치하여, 테룸오는 혁신 능력을 향상시키고자 합니다. 여기에는 혁신 관련 기능을 관리하는 새로운 이사 직위와 부서 간 협력을 촉진하는 것이 포함됩니다.
Terumo a établi Terumo Ventures, une organisation de Corporate Venture Capital (CVC) au sein de Terumo Americas Holding, visant à diriger les investissements en ventures du groupe. Terumo Ventures investira 75 millions de US$ au cours des cinq prochaines années dans des entreprises en phase de démarrage dans des domaines tels que les maladies cardiovasculaires, le traitement des maladies chroniques et les technologies numériques. Le CVC opère dans des hubs d'innovation mondiaux, tels que le Massachusetts et la Californie.
Depuis 2013, Terumo construit des relations avec des startups Medtech grâce à des investissements dans des fonds de capital-risque aux États-Unis et en Chine. Le nouveau CVC vise à accroître l'agilité dans l'identification et l'exécution des investissements en venture, en accélérant l'acquisition de technologies de pointe et en développant un pipeline solide de fusions et acquisitions.
Aligné avec sa stratégie de croissance quinquennale 'GS26' et sa vision à long terme 'Des dispositifs aux solutions', Terumo vise à améliorer ses capacités d'innovation. Cela comprend un nouveau poste de directeur pour gérer les fonctions liées à l'innovation et favoriser la collaboration interfonctionnelle.
Terumo hat Terumo Ventures gegründet, eine Corporate Venture Capital (CVC) Organisation innerhalb von Terumo Americas Holding, die darauf abzielt, die Venture-Investitionen der Gruppe zu leiten. Terumo Ventures wird in den nächsten fünf Jahren 75 Millionen US$ in Frühphasenunternehmen in Bereichen wie Herz-Kreislauf-Erkrankungen, Behandlung chronischer Krankheiten und digitale Technologien investieren. Der CVC agiert in globalen Innovationszentren wie Massachusetts und Kalifornien.
Seit 2013 baut Terumo Beziehungen zu Medtech-Startups durch Investitionen in Venture-Capital-Fonds in den USA und China auf. Der neue CVC hat das Ziel, die Agilität bei der Identifikation und Durchführung von Venture-Investitionen zu erhöhen, den Erwerb modernster Technologien zu beschleunigen und eine robuste M&A-Pipeline zu entwickeln.
Im Einklang mit der 5-Jahres-Wachstumsstrategie 'GS26' und der langfristigen Vision 'Von Geräten zu Lösungen' möchte Terumo die Innovationskapazitäten verbessern. Dies beinhaltet eine neue Direktorenposition zur Leitung der innovationsbezogenen Funktionen und zur Förderung der abteilungsübergreifenden Zusammenarbeit.
- Terumo Ventures will invest US$ 75 million over the next five years.
- New CVC increases agility in venture investments, enhancing technology acquisition.
- Aligned with 5-Year Growth Strategy 'GS26' and the long-term vision of 'From Devices to Solutions.'
- Introduction of a new director position to centrally manage innovation-related functions.
- None.
Terumo Ventures operates in global innovation hubs around the world, such as
Terumo has been building relationships with medtech start-ups by investing in venture capital funds in
With the 5-Year Growth Strategy "GS26" and its long-term vision of "From Devices to Solutions," Terumo is committed to delivering innovative and comprehensive solutions to various medical challenges and unmet needs.
As part of this effort, the company has been working to strengthen its innovation capabilities. This includes the introduction of the new director position in charge of innovation in April 2024. The position centrally manages innovation-related functions across the company, such as R&D, intellectual property, clinical development, digital transformation, and venture investment, and facilitates cross-functional collaboration.
Going forward, Terumo will continue to enhance its ability to create innovation through a combination of internal development and partnerships with external parties to further expand the value it provides to society.
For more information on Terumo Ventures, please visit https://www.terumo.com/terumo-ventures.
About Terumo
Terumo (TSE:4543) is a global leader in medical technology and has been committed to "Contributing to Society through Healthcare" for 100 years. Based in
View original content to download multimedia:https://www.prnewswire.com/news-releases/terumo-establishes-corporate-venture-capital-terumo-ventures-302214918.html
SOURCE Terumo Corporation
FAQ
What is Terumo Ventures?
How much will Terumo Ventures invest and over what period?
In which fields will Terumo Ventures invest?
Where will Terumo Ventures operate?
What is Terumo's 5-Year Growth Strategy?
What new position did Terumo introduce in April 2024?
